Insider · CIK 0001242825

LEIDEN JEFFREY M

Reports to the SEC for 5 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001242825

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-11	ODTXOdyssey Therapeutics, Inc.C Conversion	Director	CConversion	+28.7K sh	—	—	28,698
2026-05-11	ODTXOdyssey Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,963 sh	—	—	31,661
2026-05-11	ODTXOdyssey Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−17 sh	$18.00	−$306	31,644
2026-05-11	ODTXOdyssey Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−79.2K sh	—	—	0
2026-05-11	ODTXOdyssey Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−100K sh	—	—	0
2026-05-11	ODTXOdyssey Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion	Director	CConversion	−96K sh	—	—	0
2026-05-11	ODTXOdyssey Therapeutics, Inc. · Series D Warrants (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−28.8K sh	—	—	0
2026-05-08	ODTXOdyssey Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$20.00	+$100K	270,198
2026-05-07	ODTXOdyssey Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+626K sh	—	—	626,220
2026-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, Executive Chairman	FTax Payment	−3,547 sh	$485.11	−$1.72M	34,797
2026-02-18	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, Executive Chairman	FTax Payment	−2,964 sh	$483.75	−$1.43M	38,344
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, Executive Chairman	AAward	+8,269 sh	—	—	41,308
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, Executive Chairman	AAward	+9,012 sh	—	—	33,039
2025-12-04	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+1 sh	$91.05	+$91.05	24,027
2025-12-04	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−1 sh	—	—	0
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+63.8K sh	$86.52	+$5.52M	87,807
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−4,469 sh	$440.40	−$1.97M	83,338
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−1,320 sh	$441.26	−$582K	82,018
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−2,469 sh	$443.21	−$1.09M	79,549
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−4,352 sh	$444.36	−$1.93M	75,197
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−7,899 sh	$445.56	−$3.52M	67,298
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−1,152 sh	$447.05	−$515K	66,146
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−2,320 sh	$448.78	−$1.04M	63,826
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−5,880 sh	$449.84	−$2.65M	57,946
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−5,809 sh	$451.20	−$2.62M	52,137
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−15.7K sh	$452.20	−$7.09M	36,456
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−10.4K sh	$453.34	−$4.7M	26,096
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−2,070 sh	$455.22	−$942K	24,026
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−63.8K sh	—	—	0
2025-11-14	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+13.8K sh	$91.05	+$1.26M	37,861
2025-11-14	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+39.8K sh	$86.52	+$3.44M	77,630
2025-11-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−32.2K sh	$440.30	−$14.2M	45,396
2025-11-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−21.3K sh	$441.35	−$9.41M	24,066
2025-11-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−40 sh	$442.00	−$17.7K	24,026
2025-11-14	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−13.8K sh	—	—	1
2025-11-14	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−39.8K sh	—	—	63,781
2025-11-13	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+19.7K sh	$91.05	+$1.79M	43,714
2025-11-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−18.5K sh	$440.22	−$8.16M	25,186
2025-11-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−1,160 sh	$441.05	−$512K	24,026
2025-11-13	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−19.7K sh	—	—	13,836
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, Executive Chairman	FTax Payment	−6,066 sh	$463.46	−$2.81M	24,026
2025-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, Executive Chairman	FTax Payment	−2,525 sh	$450.83	−$1.14M	30,092
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, Executive Chairman	AAward	+7,209 sh	—	—	32,617
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, Executive Chairman	AAward	+15.4K sh	—	—	25,408
2024-08-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−3,784 sh	$499.00	−$1.89M	9,994
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, Executive Chairman	FTax Payment	−4,118 sh	$420.58	−$1.73M	13,778
2024-02-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−4,655 sh	$419.16	−$1.95M	17,896
2024-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−4,356 sh	$419.04	−$1.83M	22,551
2024-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−737 sh	$419.13	−$309K	26,907
2024-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, Executive Chairman	SSale	−2,009 sh	$419.22	−$842K	28,291

Recent filings

Accepted (ET)
May 114
LEIDEN JEFFREY M0001193125-26-217607
SEC(opens sec.gov)
Feb 264
LEIDEN JEFFREY M0001242825-26-000002
SEC(opens sec.gov)
Feb 194
LEIDEN JEFFREY M0000875320-26-000092
SEC(opens sec.gov)
Jan 264
LEIDEN JEFFREY M0000875320-26-000020
SEC(opens sec.gov)
Dec 54
LEIDEN JEFFREY M0000875320-25-000242
SEC(opens sec.gov)

Companies

Address

C/O ODYSSEY THERAPEUTICS, INC. 51 SLEEPER STREET, SUITE 800

BOSTON, MA, 02210